Company page

Benitec Biopharma Inc.

Benitec Biopharma Inc. (BNTC) is a public company based in the United States, specializing in innovative biotechnology solutions. With a market capitalization of approximately $417.4 million, the company focuses on developing therapeutic treatments using its proprietary gene-silencing technology. Benitec aims to address significant unmet medical needs through its research and development efforts.